Investor Artisan Partners fordert Aufspaltung von Bayer

Siemens Healthineers wachsen wieder

Boehringer Ingelheim auf dem Weg zum Mega-Blockbuster

Robotic medicine: Setback for Siemens Healthineers

Research-development country Germany

How the new CEO Bayer has to move forward

How the new CEO Bayer has to move forward

Two Morphosys drugs are showing promise

Eleven European stocks with high potential